Cleared Traditional

K020817 - LIQUICHEK URINE CHEMISTRY CONTROL

K020817 is the FDA 510(k) clearance for LIQUICHEK URINE CHEMISTRY CONTROL by Bio-Rad Laboratories, Inc.. It is a Class 1 Chemistry device (product code JJY) cleared through the Traditional 510(k) pathway after a 30-day FDA review.

K020817 · Bio-Rad Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2002
Decision
30d
Days
Class 1
Risk

K020817 is an FDA 510(k) clearance for the LIQUICHEK URINE CHEMISTRY CONTROL. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Bio-Rad Laboratories, Inc. (Irvine, US). The FDA issued a Cleared decision on April 12, 2002 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad Laboratories, Inc. devices

Submission Details

510(k) Number K020817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2002
Decision Date April 12, 2002
Days to Decision 30 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 88d · This submission: 30d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 342
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K020817.
LYPHOCHEK WHOLE BLOOD CONTROL, MODELS 561, 562, 563
K022041 · Bio-Rad Laboratories, Inc. · Jul 2002
MEDICA EASYQC BLOOD GAS/ELECTROLYTE CONTROL
K021930 · Bionostics, Inc. · Jun 2002
MODIFICATION TO N/T RHEUMATOLOGY CONTROLS SL 1 & 2
K021381 · Dade Behring, Inc. · Jun 2002
MODIFICATION TO VIGIL LIPID CONTROL
K020521 · Beckman Coulter, Inc. · Mar 2002
MODIFICATION TO MAS CARDIOLMMUNE TL
K013995 · Medical Analysis Systems, Inc. · Dec 2001
MAS LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL 1 AND 2, DADE LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL
K013734 · Medical Analysis Systems, Inc. · Dec 2001